New PCR multiplexes for sex typing of ostriches

by W. Malagó-Jr., A. Medaglia, E. Matheucci-Jr., F. Henrique-Silva

Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature

by L. Siracusa, A. Cascio, S. Giordano, A. A. Medaglia, G. A. Restivo, I. Pirrone, G. F. Saia, F. Collura, C. Colomba
Published 2021-06-01

Impact of prolonged dose delays on response with belantamab mafodotin (belamaf; gsk2857916) treatment in dreamm-2 study: 13-month follow-up

by A. Medaglia, A.D. Cohen, H.C. Lee, S. Trudel, A-O. Abdallah, N. Callander, E. Libby, L. Karlin, S. Lonial, L. Womersley, J. Baron, E. Lewis, K. Nungesser, I. Gupta, J. Opalinska
Published 2020-09-01

Dreamm-4: evaluating safety and clinical activity of belantamab mafodotin (belamaf) in combination with pembrolizumab in patients with relapsed/refractory multiple myeloma (rrmm)

by A. Medaglia, A.K. Nooka, M.V.M. Manteca, N. Bahlis, K. Weisel, A. Oriol, A.A. Alonso, A. Suvannasankha, B. Holkova, K. Luptakova, D. Fecteau, B.E. Kremer, M. Nichols, D. Williams, D.A Smith, R.C. Jewell, R. Montes de Oca, J. Opalinska, S. Trudel
Published 2020-09-01

Dreamm-2: single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma (rrmm), including subgroups with renal impairment (ri) and high-risk (hr) cytogen...

by S. Lonial, H.C. Lee, A. Badros, S. Trudel, A.K. Nooka, A. Chari, A-O. Abdallah, N.S. Callander, D.W. Sborov, A. Suvannasankha, K. Weisel, P.M. Voorhees, M. Hultcrantz, E.N. Libby, P.G. Richardson, P. Rodriguez Otero, B. Besemer, T. Facon, A. Hoos, J. Baron, T. Piontek, R.C. Jewell, E. Lewis, J. Opalinska, I. Gupta, A.D. Cohen, A. Medaglia
Published 2020-09-01